Stock Scorecard
Stock Summary for AC Immune SA (ACIU) - $2.77 as of 6/1/2026 6:51:20 PM EST
Total Score
7 out of 30
Safety Score
25 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ACIU
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ACIU
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ACIU
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ACIU
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ACIU (25 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ACIU
Financial Details for ACIU
Company Overview |
|
|---|---|
| Ticker | ACIU |
| Company Name | AC Immune SA |
| Country | USA |
| Description | AC Immune SA, a clinical-stage biopharmaceutical company, discovers, designs and develops drugs and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company is headquartered in Lausanne, Switzerland. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 2.77 |
| Price 4 Years Ago | 2.04 |
| Last Day Price Updated | 6/1/2026 6:51:20 PM EST |
| Last Day Volume | 293,110 |
| Average Daily Volume | 248,017 |
| 52-Week High | 4.00 |
| 52-Week Low | 1.60 |
| Last Price to 52 Week Low | 73.13% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 32.57 |
| Sector PE | 47.20 |
| 5-Year Average PE | -7.67 |
| Free Cash Flow Ratio | 14.58 |
| Industry Free Cash Flow Ratio | 19.46 |
| Sector Free Cash Flow Ratio | 35.13 |
| Current Ratio Most Recent Quarter | 0.87 |
| Total Cash Per Share | 0.19 |
| Book Value Per Share Most Recent Quarter | 0.41 |
| Price to Book Ratio | 7.43 |
| Industry Price to Book Ratio | 12.11 |
| Sector Price to Book Ratio | 20.65 |
| Price to Sales Ratio Twelve Trailing Months | 78.63 |
| Industry Price to Sales Ratio Twelve Trailing Months | 9.31 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.85 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 101,774,000 |
| Market Capitalization | 281,913,980 |
| Institutional Ownership | 24.83% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -38.36% |
| Reported EPS 12 Trailing Months | -0.84 |
| Reported EPS Past Year | -0.15 |
| Reported EPS Prior Year | -0.70 |
| Net Income Twelve Trailing Months | -66,221,000 |
| Net Income Past Year | -70,447,000 |
| Net Income Prior Year | -50,916,000 |
| Quarterly Revenue Growth YOY | 13.00% |
| 5-Year Revenue Growth | -25.37% |
| Operating Margin Twelve Trailing Months | -1,322.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 19,169,000 |
| Total Cash Past Year | 26,825,438 |
| Total Cash Prior Year | 36,275,000 |
| Net Cash Position Most Recent Quarter | 19,169,000 |
| Net Cash Position Past Year | 26,825,438 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 44,934,988 |
| Total Stockholder Equity Prior Year | 112,270,000 |
| Total Stockholder Equity Most Recent Quarter | 31,534,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -50,923,857 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.50 |
| Free Cash Flow Past Year | -67,007,722 |
| Free Cash Flow Prior Year | 65,266,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 2.41 |
| 20-Day Bollinger Middle Band | 2.97 |
| 20-Day Bollinger Upper Band | 3.52 |
| Beta | 1.65 |
| RSI | 40.75 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 6/1/2026 4:25:03 PM EST |